Form 4: Chemed CEO Receives Stock Grant
Insider Transaction (Form 4)
Joel L Wherley, CEO - Vitas Healthcare of Chemed Corp, received 12,686 shares of common stock on October 20, 2026.
Summary
- Grant/award: acquired 12,686 Stock Option (right to buy with tandem tax withholding) at $512.64 ($6,503,351) on October 20, 2026; holds 42,906 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joel L Wherley — Officer (CEO - Vitas Healthcare)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-20 | Grant/award | Stock Option (right to buy with tandem tax withholding) | 12,686 | $513 | $6.5M | 42,906 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-20 | Grant/award (12,686 shares) |
Keywords
insider transaction, Form 4, CHE, CHEMED CORP, neutral, Joel L Wherley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.